Related by context. All words. (Click for frequent words.) 77 pertuzumab 73 carboplatin paclitaxel 73 HGS# 73 mapatumumab 72 sorafenib Nexavar ® 72 MGd 72 evaluating tivozanib 72 docetaxel Taxotere R 71 PXD# 71 neratinib 71 FOLFOX6 chemotherapy regimen 71 trastuzumab Herceptin R 70 cilengitide 70 decitabine 70 sorafenib tablets 70 pegylated liposomal doxorubicin 70 enzastaurin 70 HGS ETR1 70 IMC A# 70 HGS ETR2 70 CA4P 70 INCB# [001] 70 HER2 positive metastatic breast 70 BRAF inhibitor 70 Sym# 70 HuMax EGFr 70 Aflibercept 69 erlotinib Tarceva ® 69 talabostat 69 PSMA ADC 69 Pertuzumab 69 anti EGFR antibody 69 YONDELIS 69 vidofludimus 69 AEG# 69 bevacizumab Avastin ® 69 ENMD # 69 OMP #M# 69 CIMZIA TM 69 pomalidomide 69 Blinatumomab 69 NXL# 69 docetaxel Taxotere 69 cetuximab Erbitux ® 68 IMA# 68 docetaxel chemotherapy 68 ixabepilone 68 Nexavar ® 68 CD# antibody [001] 68 MAGE A3 ASCI 68 Elotuzumab 68 gemcitabine carboplatin 68 CYT# potent vascular disrupting 68 Vandetanib 68 nab paclitaxel 68 teriflunomide 68 XmAb# 68 Azedra 68 vorinostat 68 axitinib 68 OXi# 68 bortezomib Velcade R 68 PKC# 68 PD LID 68 metaglidasen 68 docetaxel Taxotere ® 68 Proxinium TM 68 alvespimycin 68 immunomodulator 68 milatuzumab 68 ZOLINZA 68 elotuzumab 68 Carfilzomib 68 EGFr 67 HuLuc# 67 lenalidomide dexamethasone 67 telaprevir dosed 67 galiximab 67 MEK inhibitor 67 FOLFOX chemotherapy 67 ZACTIMA 67 low dose cytarabine 67 tanespimycin 67 Symadex 67 paclitaxel Taxol ® 67 PEG SN# 67 liposomal doxorubicin 67 Virulizin ® 67 Trastuzumab 67 Taxotere ® 67 Phase 1b trial 67 rHuPH# 67 R#/MEM # 67 cisplatin vinorelbine 67 MetMAb 67 Teriflunomide 67 fosbretabulin 67 Hsp# Inhibitor 67 Sapacitabine 67 chemotherapy FOLFOX 67 zalutumumab 67 Fludara 67 Amplimexon 67 Traficet EN 67 entinostat 67 thalidomide Thalomid 67 sorafenib Nexavar R 67 SCH # 67 obatoclax 67 Xelox 67 IgG1 antibody 67 sorafenib Nexavar 67 Aptivus ® 67 gemcitabine chemotherapy 67 Glufosfamide 67 dacetuzumab 66 Pegasys ® 66 orally bioavailable 66 custirsen 66 relapsed MM 66 Targretin 66 BRIM2 66 bortezomib Velcade ® 66 deforolimus 66 valopicitabine 66 GRN#L 66 Panzem R NCD 66 tumor xenograft models 66 angiogenesis inhibitor 66 5 fluorouracil leucovorin 66 tyrosine kinase inhibitor 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 viral kinetics 66 adecatumumab 66 favorable pharmacokinetic profile 66 ritonavir boosted 66 T DM1 66 Aliskiren 66 pan HDAC inhibitor 66 azacytidine 66 PEG Interferon lambda 66 R sorafenib tablets 66 DAVANAT 66 ACTEMRA TM 66 Epratuzumab 66 HSP# inhibitor 66 Pemetrexed 66 dacarbazine 66 humanised monoclonal antibody 66 Gemzar ® 66 Linaclotide 66 aflibercept VEGF Trap 66 CCX# 66 BAY #-# 66 CHOP chemotherapy 66 ascending dose 66 Tanespimycin 66 adalimumab Humira 66 relapsed multiple myeloma 66 oral prodrug 66 bortezomib Velcade 66 EndoTAGTM 1 66 orally administered inhibitor 66 thymalfasin 66 Bortezomib 66 hA# 66 Gemcitabine 66 sunitinib malate 66 Lenocta 66 antiangiogenic 66 pharmacodynamic profile 66 MEK inhibitors 66 INSPIRE Trial Phase III 66 MYDICAR ® 66 vinca alkaloid 66 Voreloxin 65 FOLFIRI chemotherapy 65 Golimumab 65 maximally tolerated dose 65 standard chemotherapy regimen 65 xenograft models 65 Doxil 65 FOLFOX 65 Tyrima 65 Azixa 65 paclitaxel Taxol 65 ganetespib 65 ospemifene 65 Fludara ® 65 PI3K/Akt pathway inhibitor 65 phase IIa clinical 65 gemcitabine Gemzar 65 volociximab 65 TG# [003] 65 forodesine 65 liposomal formulation 65 Capesaris 65 somatostatin analog 65 rNAPc2 65 relapsing multiple sclerosis 65 Vidaza ® 65 standard chemotherapy regimens 65 irinotecan chemotherapy 65 demonstrated antitumor activity 65 CIMZIA ™ 65 HGS ETR1 mapatumumab 65 FOLFIRI 65 JAK inhibitors 65 Omacetaxine 65 Velcade bortezomib 65 daunorubicin 65 antitumor activity 65 APTIVUS r 65 Aplidin R 65 Omacetaxine mepesuccinate 65 APOPTONE 65 HQK 65 preclinical efficacy 65 Seliciclib 65 Irinotecan 65 OncoVEX GM CSF 65 cediranib 65 CBLC# 65 regorafenib 65 Xeloda ® 65 seliciclib 65 Allovectin 7 R 65 oral deforolimus 65 plus dexamethasone 65 trabectedin 65 KRAS mutations occur 65 Xcytrin 65 Imprime PGG ® 65 potent antiproliferative 65 Archexin 65 tenofovir emtricitabine 65 metastatic HRPC 65 Platinol ® cisplatin 65 bendamustine 65 mertansine 65 HuMax CD# 65 somatostatin analogue 65 Panzem R 65 tocilizumab 65 gemcitabine cisplatin 65 CoFactor 65 Dapagliflozin 65 5 FU leucovorin 65 OHR/AVR# 65 Allovectin 7 ® 65 antibody MAb 65 Talabostat 65 novel VDA molecule 65 Elvitegravir 65 lintuzumab 65 Chemophase 65 active comparator 65 multicenter Phase II 65 immunotherapeutic agent 65 Alocrest 65 DU #b 65 IMP# 65 melphalan prednisone 65 DOXIL 65 pharmacodynamic effects 65 Taxotere R 65 CD# monoclonal antibody 65 HCD# [002] 65 fenofibric acid 65 RoACTEMRA 65 interferon alfa 2a 65 Phase Ib II 65 anti angiogenic agent 65 PREZISTA r 65 YONDELIS R 65 Perifosine 65 Pegasys R 65 CIMZIA TM certolizumab pegol 65 CR# vcMMAE 65 Phase Ib clinical 65 chimeric monoclonal antibody 65 preclinically 65 TRAIL R2 65 temsirolimus Torisel ® 64 veltuzumab 64 plus gemcitabine 64 Bavituximab 64 Interferon alpha 64 estramustine 64 immunomodulatory 64 CTAP# Capsules 64 bevacizumab Avastin R 64 tesmilifene 64 huN# DM1 64 PARP inhibitor 64 Aplidin 64 fluoropyrimidine 64 EFAPROXYN 64 IAP inhibitor 64 Herceptin trastuzumab 64 pegylated interferon alfa 2b 64 refractory chronic lymphocytic 64 Annamycin 64 PREZISTA rtv 64 REOLYSIN ® 64 aflibercept 64 ZYBRESTAT 64 cisplatin gemcitabine 64 ofatumumab 64 angiotensin receptor blocker ARB 64 radiolabeled TM# 64 LY# [003] 64 farletuzumab 64 romidepsin 64 Xanafide 64 motesanib 64 imatinib Gleevec ® 64 intratumoral injection 64 oral Azacitidine 64 PI3K inhibitor 64 IRX 2 64 PDE4 inhibitor 64 proteasome inhibitor bortezomib 64 ASONEP 64 immune modulating 64 cetuximab Erbitux R 64 Tarceva TM 64 TLR agonists 64 idarubicin 64 Ceplene/IL-2 64 refractory metastatic 64 anticancer therapies 64 RG# [001] 64 lenalidomide Revlimid R 64 diabetic neuropathic pain 64 TTF Therapy 64 EGFR HER2 64 trastuzumab Herceptin 64 recurrent glioblastoma 64 Bicifadine 64 MGCD# [001] 64 ELACYT 64 cisplatin chemotherapy 64 dose cytarabine 64 virus HCV protease inhibitor 64 urocortin 2 64 Tarvacin 64 selective orally bioavailable 64 cytokine refractory 64 Deforolimus 64 Actilon 64 investigational monoclonal antibody 64 vascular disrupting agent 64 elvitegravir 64 cyclophosphamide doxorubicin vincristine 64 DEB# 64 PRT# 64 luteinizing hormone releasing 64 azacitidine 64 Doxil ® 64 omega interferon 64 ELOXATIN 64 Tarvacin TM 64 reslizumab 64 EOquin TM 64 Vidofludimus 64 Neulasta R 64 plus prednisone 64 Amrubicin 64 metastatic CRC 64 Vilazodone 64 amrubicin 64 metastatic hormone refractory 64 TriRima 64 ACAPODENE 64 LHRH antagonists 64 oral antiviral 64 iSONEP 64 selective androgen receptor modulator 64 placebo controlled clinical 64 Vidaza azacitidine 64 ZK EPO 64 EndoTAG TM -1 64 Panzem NCD 64 TORISEL 64 metastatic colorectal 64 oral chemotherapeutic agent 64 #I TM# 64 Abiraterone acetate 64 Ceflatonin 64 INT# [002] 64 pegylated interferon alfa 2a 64 ThermoDox R 64 sipuleucel T 64 alefacept 64 sunitinib Sutent ® 64 G CSF 64 Copegus ribavirin 64 humanized anti 64 recurrent glioblastoma multiforme 64 OncoVEX 64 Novolimus 64 IMiDs ® 64 capecitabine Xeloda 64 imetelstat 64 TRO# 64 KRN# 64 bevacizumab Avastin 64 perifosine 64 antitumor effects 64 proteasome inhibitor 64 interferon alfa 64 Erbitux cetuximab 64 GSK# [001] 64 glufosfamide 64 AVONEX ® 64 Nanobody 64 S/GSK# 64 potent anti angiogenic 64 alemtuzumab Campath 64 receptor tyrosine kinase inhibitor 64 visilizumab 64 AEGR 64 sodium glucose cotransporter 64 dasatinib Sprycel 64 PS# [001] 64 pharmacodynamic PD 63 IgG1 monoclonal antibody 63 protein tyrosine phosphatase 1B 63 etoposide 63 evaluating satraplatin 63 NGX# 63 antitumor 63 intravesical infusion therapy 63 GAMMAGARD 63 IMC #B 63 temsirolimus 63 antiangiogenic therapy 63 PROCHYMAL 63 CCR9 antagonist 63 primary hypercholesterolemia 63 Degarelix 63 RGB # 63 celgosivir 63 humanised antibody 63 APTIVUS 63 cMET 63 Zalypsis 63 blinded randomized placebo controlled 63 histone deacetylase inhibitor 63 mTOR inhibitors 63 febuxostat 63 TYKERB 63 immunomodulating 63 nucleoside analog 63 rituximab Rituxan 63 goserelin 63 alfa 2a 63 ZD# [001] 63 comparator arm 63 DMARDS 63 IFN α 63 sapacitabine 63 Folfox 63 AMD# [003] 63 trodusquemine 63 ascending doses 63 oral picoplatin 63 Oral NKTR 63 pemetrexed 63 protein kinase inhibitor 63 riociguat 63 anti leukemic 63 Phase Ib clinical trials 63 iniparib 63 paclitaxel poliglumex 63 Sandostatin LAR Depot 63 GW# [003] 63 anakinra 63 Vicinium TM 63 TNF Tumor Necrosis Factor 63 TLR9 agonist 63 anticancer agent 63 ADP receptor antagonist 63 Phase 1b clinical trials 63 infliximab monotherapy 63 monoclonal antibody IgG1 Mab 63 chemotherapeutic drug 63 Campath alemtuzumab 63 multitargeted 63 relapsed ovarian cancer 63 JAK inhibitor 63 Cytoxan 63 gemcitabine 63 velafermin 63 Eculizumab 63 IMiDs 63 Reolysin 63 aspirin clopidogrel 63 SYN# 63 oral dnaJP1 63 pemetrexed Alimta 63 flavopiridol 63 radezolid 63 SCCHN 63 BMS # 63 Darinaparsin 63 Increlex ® 63 interferon alfa 2b 63 cetuximab 63 Lubiprostone 63 Zolinza 63 DepoVax 63 Quinamed 63 MDV# 63 TREANDA 63 anti CD3 63 ADVEXIN 63 temozolomide 63 relapsed refractory multiple myeloma 63 Gefitinib 63 investigational humanized monoclonal antibody 63 multi kinase inhibitor 63 Squalamine 63 Telatinib 63 oral ridaforolimus 63 sargramostim 63 GMX# 63 ceftaroline 63 ThermoDox 63 mTOR mammalian target 63 5-FU/LV 63 radiolabeled monoclonal antibody 63 HuMax CD4 63 trastuzumab 63 Ixempra 63 Melphalan 63 panitumumab Vectibix 63 TELCYTA 63 targeted antifolate 63 LymphoStat B belimumab 63 Dasatinib 63 THR beta agonist 63 humanized monoclonal antibody 63 alpha 2b 63 Phase Ib study 63 interferon gamma 1b 63 Boceprevir 63 apremilast 63 lapatinib Tykerb 63 Exelixis compounds 63 PHX# 63 IMiDs R 63 infusional 5-FU/LV 63 topotecan 63 Daclizumab 63 AP# [003] 63 CCX# B 63 PEGylated Fab fragment 63 mTOR inhibitor 63 Zorbtive TM 63 Ocrelizumab 63 GRN# 63 radiation sensitizer 63 vascular disrupting agents 63 peptide antigens 63 afatinib 63 tubulin inhibitor 63 CYC# 63 VELCADE melphalan 63 lumiliximab 63 CYT# 63 anti proliferative 63 5 Fluorouracil 63 docetaxel 63 Talactoferrin 63 CXB# 63 immunostimulatory 63 CORT # 63 nitazoxanide 63 antiproliferative effects 63 pain palliation 63 baminercept 63 sodium thiosulfate STS 63 Afatinib 63 CRLX# 63 PEGylated interferon beta 1a 63 Bevacizumab 63 OMP #R# 63 mycophenolate mofetil 63 tranilast 63 ongoing Phase 1b 63 administered intranasally 63 IMiDs ® compound 63 Vidaza R 63 MEK Inhibitor 63 alpha folate receptor 63 ISENTRESS 63 oral salmon calcitonin 63 ISIS # 63 epirubicin cyclophosphamide 63 p# biomarker 63 PRTX 63 alpha 2a 62 Preclinical studies suggest 62 LY# [002] 62 Halozyme Ultrafast Insulin 62 paclitaxel cisplatin 62 CANCIDAS 62 Maribavir 62 Angiolix 62 Cloretazine 62 ACTEMRA 62 doxorubicin docetaxel 62 thrombopoietin 62 DexaSite 62 acyclovir Lauriad R 62 oblimersen 62 Nexavar sorafenib 62 peginterferon alfa 2b 62 molecularly targeted 62 Pharmacokinetics PK 62 Phase 1b 62 Phase IIa trials 62 uric acid lowering 62 Cimzia ® certolizumab pegol 62 Etoposide 62 Kahalalide F 62 targeting CD# 62 IAP inhibitors 62 EGF receptor 62 TLK# 62 anticancer activity 62 Allovectin 7 62 randomized Phase III 62 GLPG# 62 imexon 62 AKT inhibitor 62 dasatinib Sprycel ® 62 pathophysiological effects 62 interferon IFN 62 vinorelbine 62 CINQUIL 62 ChronVac C R 62 Onconase 62 FOLFOX6 62 ocular formulation 62 HMG CoA reductase inhibitors 62 heavily pretreated 62 trabedersen 62 colesevelam HCl 62 RAV# 62 Tesetaxel 62 etanercept Enbrel 62 Protelos 62 corticosteroid dexamethasone 62 selective kinase inhibitor 62 Romidepsin 62 cyclophosphamide chemotherapy 62 pharmacokinetics PK 62 Vitaxin 62 Combo Stent 62 GVAX ® 62 Neulasta ® 62 Delcath PHP System 62 VEGF inhibitors 62 JAK2 inhibitor 62 GVAX Pancreas Vaccine 62 Peg IFN 62 phase IIb clinical 62 Cetuximab Erbitux 62 capecitabine Xeloda R 62 Epothilones 62 rHuPH# enzyme 62 cannabinor 62 CTA# Injection 62 Pazopanib 62 PRX # 62 Cloretazine R VNP#M 62 Tarceva erlotinib 62 uricase 62 PrevOnco ™ 62 ibandronate 62 FOLPI 62 LymphoStat B TM 62 talactoferrin 62 metastatic renal cell carcinoma 62 Rigel R# 62 neoadjuvant 62 canakinumab 62 Ophena 62 RG# ITMN 62 dexpramipexole 62 investigational protease inhibitor 62 docetaxel prednisone 62 gemcitabine Gemzar ® 62 Pegylated Interferon 62 plus prednisone prednisolone 62 gefitinib Iressa 62 Imetelstat 62 PI3K/mTOR 62 xanthine oxidase inhibitor 62 kidney urologic 62 oral rivaroxaban 62 registrational trial 62 PEG interferon 62 Camptosar ® 62 Panitumumab 62 NLX P# 62 #mg BID [001] 62 refractory AML 62 refractory CLL 62 bortezomib 62 IL# PE#QQR 62 synthetic retinoid 62 Xeloda capecitabine 62 dacarbazine DTIC 62 Elitek 62 potent anticancer 62 DFMO 62 alpha interferons 62 Pivotal Phase 62 Apixaban 62 LBH# 62 Doxorubicin 62 polymerase inhibitor 62 RhuDex ® 62 erythropoietic 62 trastuzumab emtansine T DM1 62 elesclomol 62 PI3K Akt 62 Triapine R 62 antiangiogenic activity 62 vWF 62 JVRS 62 HDACi 62 TELINTRA 62 oxidative stress inducer 62 histone deacetylase HDAC inhibitor 62 tezampanel 62 RLY# 62 Elesclomol 62 assessing T DM1 62 Clolar ® 62 pharmacodynamic properties 62 Nexavar sorafenib tablets 62 selective modulator 62 Cotara 62 APTIVUS R 62 TRV# [001] 62 Granulocyte Colony Stimulating Factor 62 Dacogen injection 62 multiple myeloma MM 62 PEGylated anti 62 YERVOY 62 Marqibo 62 multicenter Phase III 62 BCR ABL inhibitor 62 subcutaneously administered 62 ZFP TF 62 systemic antifungal 62 CanAg 62 clevidipine 62 KNS # 62 FOLOTYN ® 62 Amphinex ® 62 cytotoxic agents 62 Temsirolimus 62 epigenetic therapies 62 paclitaxel carboplatin 62 oral allopurinol 62 peptibody 62 methotrexate MTX 62 humanized antibody 62 Gleevec resistant 62 brivaracetam 62 ONCASPAR 62 Pradefovir 62 trastuzumab Herceptin ® 62 Cisplatin 62 carboplatin chemotherapy 62 trans retinoic acid 62 oral levofloxacin 62 sclerostin 62 BZL# 62 Lenalidomide 62 evaluating REVLIMID 62 EOquin TM phase 62 Mitoxantrone 62 relapsed myeloma 62 refractory metastatic colorectal cancer 62 cariprazine 62 huC# DM4 62 samalizumab 62 recurrent glioma 62 platelet inhibitor 62 Davanat 62 class mGluR5 inhibitor 62 EpCAM 62 Darusentan 62 Fulvestrant 62 pegylated interferon alpha 62 octreotide acetate 62 INCB# [003] 62 XYOTAX TM 62 unresectable stage 62 dextromethorphan quinidine 62 Zybrestat 62 dose escalation Phase 62 ataluren 62 LHRH receptor positive 62 Evoltra ® 62 FGFR 62 Dacogen decitabine 62 EndoTAG 62 Meets Primary Endpoint 62 SERMs 62 Fc fusion protein 62 Etanercept 62 SNT MC# 62 subcutaneous formulation 62 lymphoid malignancies 62 INTELENCE 62 meropenem 62 ularitide 62 pegfilgrastim 62 JAK3 62 #ME# 62 SPRYCEL ® 62 Sudhir Agrawal D.Phil 62 atrasentan 62 Revlimid lenalidomide 62 cancer immunotherapies 62 Avastin bevacizumab 62 HMG CoA reductase inhibitor 62 anti fibrotic 62 dexamethasone Decadron 62 Luteinizing Hormone Releasing Hormone 62 Bezielle 62 OncoGel 62 DP b# 62 anti angiogenic agents 62 Lixivaptan 62 EGFR inhibitors 62 gamma secretase inhibitor 62 paclitaxel chemotherapy 62 Rebif ® 61 biologic therapy 61 Telmisartan 61 Ixabepilone 61 Obatoclax 61 platinum refractory 61 Litx 61 oral FTY# 61 nilotinib Tasigna ® 61 doxorubicin cyclophosphamide 61 antidiabetic 61 Pegasys peginterferon alfa 2a 61 paclitaxel Taxol R 61 ZYBRESTAT fosbretabulin 61 VAPRISOL 61 pharmacokinetics pharmacodynamics 61 Neupogen ® 61 VA# [002] 61 Insegia 61 p# inhibitor 61 fallopian tube cancers 61 tolerability pharmacokinetics 61 HER2 receptor 61 GV# [001] 61 antiviral activity 61 Phase #b/#a clinical 61 MabCampath 61 AeroLEF TM 61 pharmacokinetic parameters 61 investigational HCV polymerase 61 palifosfamide 61 dasatinib 61 PRX# 61 VEGF receptor 61 vicriviroc 61 Peginterferon alfa 2b 61 varespladib 61 Tavocept 61 imatinib Gleevec 61 peptidic compound 61 MAP# 61 Taxol ® 61 TYZEKA 61 HCV protease 61 cetuximab Erbitux 61 radiation chemoradiation 61 cleavable linker 61 Multimeric 61 hematologic malignancies 61 abiraterone acetate 61 crizotinib PF # 61 CK # administered 61 Rituxan rituximab 61 Peginterferon 61 PEG PAL 61 orally dosed 61 Gliadel Wafer 61 Albuferon TM 61 Hycamtin 61 Phase III metastatic melanoma 61 Tezampanel 61 tacrolimus ointment 61 erlotinib Tarceva R 61 Smac mimetics 61 bicalutamide 61 TNF alpha inhibitor 61 nucleotide analog 61 GM CSF 61 belinostat 61 Pivotal Phase III 61 VEGF Trap 61 erlotinib 61 immune modulatory 61 sunitinib 61 davunetide intranasal AL 61 TMC# [002] 61 generation Hsp# inhibitor 61 telomerase therapeutic 61 Vascugel 61 novel peptide 61 recurrent NSCLC 61 Inhalation Solution 61 zonisamide SR 61 Zemplar Capsules 61 resminostat 61 denileukin diftitox 61 Pathway Inhibitor 61 BAL# [001] 61 BCX# 61 AzaSite Plus 61 Olaparib 61 ProLindac 61 tremelimumab 61 castrate resistant prostate cancer 61 Pralatrexate 61 seliciclib CYC# 61 ceftazidime 61 RSD# oral 61 TroVax ® 61 dose proportionality 61 Dual Opioid 61 novel immunomodulatory 61 metformin sulfonylurea 61 pyridostigmine 61 mouse xenograft models 61 anticancer agents 61 octreotide LAR 61 #HT#A 61 HRPC 61 ATL# [001] 61 Enzastaurin 61 5 fluorouracil 61 masitinib 61 IMGN# 61 Nanobody ® 61 ASA# 61 isoform selective 61 alkylating agent 61 TACI Ig 61 ALA PDT 61 Ofatumumab 61 Tamibarotene 61 receptor inhibitor 61 Tekamlo 61 pegylated interferon alfa 61 glioblastoma multiforme GBM 61 Rasilez Tekturna 61 Vaxfectin 61 TRIOLEX 61 TG# [001] 61 Antitumor Activity 61 Targretin capsules 61 Epidermal Growth Factor Receptor 61 HER2 antibody 61 eniluracil 61 investigational therapies 61 systemic RNAi therapeutic 61 Bafetinib 61 Navelbine ® 61 evaluating carfilzomib 61 Selective Electrochemical Tumor Ablation 61 microtubule inhibitor 61 IL #E 61 mitoxantrone plus 61 PLX# 61 Akt inhibitor 61 Phase 1b clinical 61 nucleoside analogs 61 plus Copegus R 61 eltrombopag 61 anti angiogenic 61 biologic DMARD 61 interferon alpha